Computationally estimated apolipoproteins B and A1 in predicting cardiovascular risk

: Raitakari OT, Makinen VP, McQueen MJ, Niemi J, Juonala M, Jauhiainen M, Salomaa V, Hannuksela ML, Savolainen MJ, Kesaniemi YA, Kovanen PT, Sundvall J, Solakivi T, Loo BM, Marniemi J, Hernesniemi J, Lehtimaki T, Kahonen M, Peltonen M, Leiviska J, Jula A, Anand SS, Miller R, Yusuf S, Viikari JSA, Ala-Korpela M

Publisher: ELSEVIER IRELAND LTD

: 2013

: Atherosclerosis

: ATHEROSCLEROSIS

: 1

: 226

: 1

: 245

: 251

: 7

: 0021-9150

DOI: https://doi.org/10.1016/j.atherosclerosis.2012.10.049(external)

Conclusions: Serum cholesterol, HDL-cholesterol and triglycerides can be used to compute clinically useful estimates of apoB and apoA1. Using this methodology, estimates of apolipoproteins could be routinely added to laboratory reports to complement lipoprotein lipids in risk assessment. (C) 2012 Elsevier Ireland Ltd. All rights reserved.

Internal medicine